chr22-16590908-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014406.5(CCT8L2):āc.1643A>Gā(p.Glu548Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014406.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCT8L2 | NM_014406.5 | c.1643A>G | p.Glu548Gly | missense_variant | 1/1 | ENST00000359963.4 | NP_055221.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCT8L2 | ENST00000359963.4 | c.1643A>G | p.Glu548Gly | missense_variant | 1/1 | 6 | NM_014406.5 | ENSP00000353048.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248824Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134422
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459078Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725792
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.1643A>G (p.E548G) alteration is located in exon 1 (coding exon 1) of the CCT8L2 gene. This alteration results from a A to G substitution at nucleotide position 1643, causing the glutamic acid (E) at amino acid position 548 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at